HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohamed Darif Selected Research

Mohamed Darif Research Topics

Disease

6Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2007 - 06/2004
5Neoplasms (Cancer)
01/2021 - 12/2005
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2006 - 11/2005
2Multiple Myeloma
01/2022 - 01/2021
2B-Cell Lymphoma (Lymphoma, B Cell)
09/2004 - 06/2004
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2007
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2007
1Chromosome Aberrations (Chromosome Abnormalities)
09/2007
1Infections
12/2005
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2004
1Thyroid Neoplasms (Thyroid Cancer)
01/2002

Drug/Important Bio-Agent (IBA)

6ibritumomab tiuxetan (Zevalin)FDA Link
09/2007 - 06/2004
4YttriumIBA
09/2007 - 09/2004
3Monoclonal AntibodiesIBA
01/2021 - 04/2006
3Alefacept (Amevive)FDA Link
01/2006 - 11/2005
2Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2021
2ixazomibIBA
01/2022 - 01/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 01/2021
2Rituximab (Mabthera)FDA Link
04/2006 - 09/2004
1pomalidomideIBA
01/2022
1Proteasome InhibitorsIBA
01/2022
1EndoglinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1carotuximabIBA
01/2021
1Axitinib (AG 013736)IBA
01/2021
1BIIB022IBA
06/2014
1Purine NucleosidesIBA
09/2007
1Alkylating AgentsIBA
09/2007
1CD20 AntigensIBA
04/2006
1AntibodiesIBA
12/2005
1Yttrium-90IBA
06/2004
1Hormones (Hormone)IBA
01/2002

Therapy/Procedure

5Therapeutics
01/2022 - 09/2004
5Radioimmunotherapy
09/2007 - 06/2004
1Drug Therapy (Chemotherapy)
09/2007
1Aftercare (After-Treatment)
09/2007